Active ingredient
Darbepoetin Alfa
14 finished FDA listings contain Darbepoetin Alfa as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- DARBEPOETIN ALFA
- Dosage forms
- Injection, Solution, Solution
- Routes
- Intravenous, Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 10 ug/.4ml · 100 ug/.5ml · 100 ug/ml · 150 ug/.3ml · 200 ug/.4ml · 200 ug/ml · 25 ug/.42ml · 25 ug/ml · 300 ug/.6ml · 40 ug/.4ml · 40 ug/ml · 500 ug/ml · 60 ug/.3ml · 60 ug/ml
- Brand names in FDA listings
- Aranesp
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 283838
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 103951 | AMGEN | 2001-09-17 | 14 |
Official labeling on DailyMed
- ARANESP (DARBEPOETIN ALFA) INJECTION, SOLUTION ARANESP (DARBEPOETIN ALFA) SOLUTION [AMGEN, INC] · version 161 · 2026-07-21
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.